Announced Tue, 26 May · 19:53 IST

The Board has considered and approved the financials for the Quarter and year ended March 31,2026.

Revenue DeclinePat Growth 25pctNegative Operating CashflowResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.0%1-day move
₹131.35
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+4.0+5.8+3.7+3.7+5.1+6.6+15.8+7.8+10.4
Up moveDown movePending
AI summary

Integrated Proteins Limited reported audited FY2026 results with total income of ₹994.06 lakh, down significantly from ₹2,149.62 lakh in FY2025 — a revenue decline of approximately 54% year-on-year. Despite the sharp revenue fall, net profit improved to ₹23.14 lakh from ₹21.30 lakh in the prior year, indicating cost control. Operating cash flow turned positive at ₹360.26 lakh, a major recovery from a negative ₹2,356.51 lakh in FY2025. The statutory auditor, B.B. Gusani & Associates, issued an unmodified (clean) opinion, confirming no going concern or audit qualifications. The company operates across five segments — Agro & Trading, Textile, Securities, Medical, and Real Estate. No related party transactions were reported, and there are no loan defaults or outstanding debt securities.

Likely market impact

The sharp revenue decline is a concern, but the company managed to grow net profit and swing operating cash flow to positive, which may provide some comfort to investors. The clean audit report removes key audit risk.